Randomized controlled trial of Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus-genotype 4 among Egyptian patients.

被引：0
|
作者：
Thakeb, FIA
Omar, MM
El Awady, MM
Isshak, SY
机构：
[1] Cairo Univ, Cairo, Egypt
[2] Theidor Bilharz Res Inst, Cairo, Egypt
[3] Acad Res & Sci, Cairo, Egypt
来源：
HEPATOLOGY | 2003年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
252
引用
收藏
页码：278A / 278A
页数：1
相关论文
共 50 条
  • [21] Peginterferon alfa-2a and ribavirin in African American and Caucasian patients with chronic hepatitis C, genotype 1
    Conjeevaram, HS
    Fried, MW
    Jeffers, LJ
    Terrault, N
    Wiley-Lucas, TE
    Afdhal, N
    Brown, RS
    Belle, SH
    Robuck, PR
    Howell, CD
    HEPATOLOGY, 2005, 42 (04) : 275A - 276A
  • [22] Treatment persistence in and cost of therapy for patients with chronic hepatitis C: Peginterferon alfa-2a plus ribavirin versus peginterferon alfa-2b plus ribavirin
    Brixner, Diana I.
    Ye, Xin
    Chu, Teng-Chiao
    Blumentals, William A.
    Hassanein, Tarek I.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (24) : 2171 - 2178
  • [23] Pegylated Interferon Alfa-2a Plus Ribavirin in Chronic Hepatitis C Patients with Genotype 6
    Pham, Thuy T.
    Ho, Dat T.
    GASTROENTEROLOGY, 2009, 136 (05) : A840 - A840
  • [24] Efficacy of daclatasvir plus peginterferon alfa and ribavirin for patients with chronic hepatitis C genotype 4 infection
    Ahmed, Hussien
    Abushouk, Abdelrahman Ibrahim
    Gadelkarim, Mohamed
    Mohamed, Arwa
    Gabr, Mohamed
    Negida, Ahmed
    BANGLADESH JOURNAL OF PHARMACOLOGY, 2017, 12 (01) : 12 - 22
  • [25] Safety of peginterferon alfa-2a plus ribavirin in a large multinational cohort of chronic hepatitis C patients
    Lee, Samuel S.
    Roberts, Stuart K.
    Berak, Hanna
    Dusheiko, Geoffrey M.
    Harley, Hugh A.
    Gane, Edward J.
    Husa, Petr
    Horsmans, Yves J.
    Hadziyannis, Stephanos J.
    Heathcote, E. Jenny
    Messinger, Diethelm
    Tatsch, Fernando
    Han, Kwang-Hyub
    Ferenci, Peter
    LIVER INTERNATIONAL, 2012, 32 (08) : 1270 - 1277
  • [26] Peginterferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4
    Hasan, F
    Asker, H
    Al-Khaldi, J
    Siddique, I
    Al-Ajmi, M
    Owaid, S
    Varghese, R
    Al-Nakib, B
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (09): : 1733 - 1737
  • [27] Impact of ribavirin dose reductions in hepatitis C virus genotype 1 patients completing peginterferon alfa-2a/ribavirin treatment
    Reddy, K. Rajender
    Shiffman, Mitchell L.
    Morgan, Timothy R.
    Zeuzem, Stefan
    Hadziyannis, Stephanos
    Hamzeh, Fayez M.
    Wright, Teresa L.
    Fried, Michael
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (01) : 124 - 129
  • [28] Treatment of Insulin Resistance with Metformin in Naive Genotype 1 Chronic Hepatitis C Patients Receiving Peginterferon Alfa-2a Plus Ribavirin
    Romero-Gomez, Manuel
    Diago, Moises
    Andrade, Raul J.
    Calleja, Jose L.
    Salmeron, Javier
    Fernandez-Rodriguez, Conrado M.
    Sola, Ricard
    Garcia-Samaniego, Javier
    Herrerias, Juan M.
    De la Mata, Manuel
    Moreno-Otero, Ricardo
    Nunez, Oscar
    Olveira, Antonio
    Duran, Santiago
    Planas, Ramon
    HEPATOLOGY, 2009, 50 (06) : 1702 - 1708
  • [29] Peginterferon alfa-2a Plus Ribavirin for HIV-HCV Genotype 1 Coinfected Patients: A Randomized International Trial
    Rodriguez-Torres, Maribel
    Slim, Jihad
    Bhatti, Laveeza
    Sterling, Richard
    Sulkowski, Mark
    Hassanein, Tarek
    Serrao, Rosario
    Sola, Ricard
    Bertasso, Anne
    Passe, Sharon
    Stancic, Saray
    HIV CLINICAL TRIALS, 2012, 13 (03): : 142 - 152
  • [30] Peginterferon Alfa-2a plus Ribavirin in Japanese Patients Infected with Hepatitis C Virus Genotype 2 Who Failed Previous Interferon Therapy
    Kanda, Tatsuo
    Nakamoto, Shingo
    Nishino, Takayoshi
    Takada, Nobuo
    Tsubota, Akihito
    Kato, Keizo
    Miyamura, Tatsuo
    Maruoka, Daisuke
    Wu, Shuang
    Tanaka, Takeshi
    Arai, Makoto
    Mikami, Shigeru
    Fujiwara, Keiichi
    Imazeki, Fumio
    Yokosuka, Osamu
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2013, 10 (01): : 43 - 49
12345